What is the current Price Target for the Hoth Therapeutics, Inc. stock?

The average Hoth Therapeutics, Inc. target price is $4.50. This is 394.23% higher than the current stock price. The highest price target is 449.15%, the lowest is 339.32%. 2 Analysts have issued a price target Hoth Therapeutics, Inc. 2026 .

How high will the Hoth Therapeutics, Inc. stock rise?

No reliable answer can be given as to how high the Hoth Therapeutics, Inc. stock will rise. The performance of stocks, including the Hoth Therapeutics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Hoth Therapeutics, Inc. stock today?

The performance of Hoth Therapeutics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Hoth Therapeutics, Inc. stock fall?

The decline in Hoth Therapeutics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Hoth Therapeutics, Inc. Forecast, price target & analysts

$0.92

0.58% today

Nasdaq, Feb 28, 07:45 pm CET

ISIN

US44148G1058

Symbol

HOTH

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Hoth Therapeutics, Inc. Target price 2025 - Analyst rating & recommendation

Hoth Therapeutics, Inc. Classifications & Recommendation:

Buy

100%

Hoth Therapeutics, Inc. Price Target

Target Price	$4.50
Price	$0.91
Potential	394.23% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target Hoth Therapeutics, Inc. 2026 . The average Hoth Therapeutics, Inc. target price is $4.50. This is 394.23% register free of charge higher than the current stock price. The highest price target is $5.00 449.15% register free of charge , the lowest is $4.00 339.32% register free of charge .
	A rating was issued by 2 analysts: 2 Analysts recommend Hoth Therapeutics, Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Hoth Therapeutics, Inc. stock has an average upside potential 2026 of 394.23% register free of charge . Most analysts recommend the Hoth Therapeutics, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '23	2024 Estimates
Earnings Per Share $	-2.30	-1.36
		40.87%
P/E		negative

1 Analysts have issued a Hoth Therapeutics, Inc. forecast for earnings per share. The average Hoth Therapeutics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2023	$-2.30
2024	$-1.36 40.87% Unlock
2025	$-0.39 71.32% Unlock
2026	$-0.46 17.95% Unlock
2027	$-0.52 13.04% Unlock
2028	$-0.82 57.69% Unlock

Current	-0.65	441.67%
2024	-0.67 3.08% Unlock
2025	-2.33 247.76% Unlock
2026	-1.98 15.02% Unlock
2027	-1.75 11.62% Unlock
2028	-1.11 36.57% Unlock

Hoth Therapeutics, Inc....

Current Hoth Therapeutics, Inc. Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
D. Boral Capital	Locked ➜ Locked	Locked	Feb 11 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 23 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 22 2025
D. Boral Capital	Locked ➜ Locked	Locked	Jan 07 2025
D. Boral Capital	Locked ➜ Locked	Locked	Nov 13 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 04 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 16 2024

Analyst Rating	Date
Locked D. Boral Capital: Locked ➜ Locked	Feb 11 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 23 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 22 2025
Locked D. Boral Capital: Locked ➜ Locked	Jan 07 2025
Locked D. Boral Capital: Locked ➜ Locked	Nov 13 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 04 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 16 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 60.51%

BioNTech SE - ADR 30.07%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now